Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.24.1.u1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenues    
Total revenues $ 40,600 $ 41,316
Cost of sales    
Total cost of sales 42,806 42,680
Gross loss (2,206) (1,364)
Operating expenses    
Research and development 19,813 23,144
Sales and marketing 11,153 9,607
General and administrative 16,217 18,202
Total operating expenses 47,183 50,953
Loss from operations (49,389) (52,317)
Interest expense (1,491) (811)
Interest and other expense, net (1,416) (71)
Loss before income taxes (52,296) (53,199)
Income tax benefit 198 557
Net loss $ (52,098) $ (52,642)
Net loss per share-basic $ (0.16) $ (0.16)
Net loss per share-diluted $ (0.16) $ (0.16)
Weighted average shares outstanding, basic 327,124,115 319,095,656
Weighted average shares outstanding, diluted 327,124,115 319,095,656
Products    
Revenues    
Total revenues $ 35,631 $ 36,697
Cost of sales    
Total cost of sales 39,019 38,891
Services    
Revenues    
Total revenues 4,969 4,619
Cost of sales    
Total cost of sales $ 3,787 $ 3,789